40 results on '"Voon, Pei Jye"'
Search Results
2. Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia
3. To refer or not? Oncology and palliative care
4. Barriers And Challenges Of Multidisciplinary Teams In Oncology Management: A Scoping Review Protocol
5. Identification of phenomic data in the pathogenesis of cancers of the gastrointestinal (GI) tract in the UK biobank
6. Malaysian Patient Perspectives on Clinical Trial Participation: Willingness, Knowledge, Perceptions, Confidence, and Religious Barriers
7. Hand-Foot Syndrome in Cancer Patients on Capecitabine: Examining Prevalence, Impacts, and Associated Risk Factors at a Cancer Centre in Malaysia
8. Development and validation of Join Clinical Trial Questionnaire (JoinCT)
9. Identification of phenomic data in the pathogenesis of cancers of the gastrointestinal (GI) tract: A UK biobank data analysis
10. Peripheral transbronchial needle aspiration-guided pinpoint cryobiopsy of lung nodule without bronchus sign: A case report
11. A new era of the Asian clinical research network: a report from the ATLAS international symposium
12. Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia
13. Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset
14. Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
15. International Collaboration on Palliative Care Development Between ASCO and the Land of Hornbills
16. Early phase oncology clinical trials in Malaysia: current status and future perspectives
17. A randomized study to measure and enhance the health-related quality of life in patients with cancer receiving immune checkpoint modulators (ME-Q).
18. Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
19. Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
20. Abstract P035: A phase 1 pharmacokinetic trial of single agent trametinib a MEK inhibitor in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study (NCI 9591)
21. Phase I Pharmacokinetic Study of Single Agent Trametinib in Patients With Advanced Cancer and Hepatic Dysfunction
22. Exploration of Patient-Related Barriers to Effective Cancer Pain Management in a Diverse Multicultural Developing Country
23. A phase 1 dose-escalation study of intravenously (IV) administered TAK-676, a novel STING agonist, alone and in combination with pembrolizumab in patients (pts) with advanced or metastatic solid tumors.
24. Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies
25. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes
26. A case of pleural thymoma presenting as bilateral pleural based mass
27. A 4-year review of surgical and oncological outcomes of endoscopic endonasal transpterygoid nasopharyngectomy in salvaging locally recurrent nasopharyngeal carcinoma
28. Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017
29. Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset
30. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer
31. Chylothorax and central vein thrombosis, an under-recognized association: a case series
32. Effect of low-dose, short-course sunitinib (Su) on tumor vasculature and tumor blood flow for enhancement of chemotherapy efficacy in breast cancer.
33. EGFR Exon 20 Insertion A763-Y764insFQEA and Response to Erlotinib—Letter
34. Correlation of aldo‐ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients
35. Correlation of pharmacokinetics of CPT-11 in FOLFIRI with phenotyping of CYP3A4 and UGT1A1 activity.
36. Low-dose, short-course sunitinib may normalize tumor vasculature and improve tumor blood flow to enhance chemotherapy efficacy in breast cancers.
37. Perceptions and barriers towards clinical trials participation in Asian cancer patients.
38. Unusual Cause of a Massive Abdominal Cystic Tumor
39. A phase II study of preoperative docetaxel, cisplatin, and capecitabine in patients with gastric carcinoma.
40. Tumour Genetics and Genomics to Personalise Cancer Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.